tiprankstipranks
Sensorion SAS (DE:RFM)
FRANKFURT:RFM
Germany Market
RFM
Sensorion SAS
RESEARCH TOOLSreports

Sensorion SAS (RFM) Stock News & Sentiment

3 Followers
Buy Rating on Sensorion SAS Driven by First-Mover GJB2 Gene Therapy SENS-601 and Strong Preclinical Proof-of-Concept
Premium
Ratings
Buy Rating on Sensorion SAS Driven by First-Mover GJB2 Gene Therapy SENS-601 and Strong Preclinical Proof-of-Concept
2M ago
Sensorion: Differentiated OTOF and GJB2 Gene Therapy Pipeline Positions Company for Best-in-Class Outcomes and Attractive Risk-Reward Into 2026
Premium
Ratings
Sensorion: Differentiated OTOF and GJB2 Gene Therapy Pipeline Positions Company for Best-in-Class Outcomes and Attractive Risk-Reward Into 2026
3M ago
Strong Buy Recommendation for Sensorion SAS Amid Promising Audiogene Study Results and Strategic Growth Prospects
Premium
Ratings
Strong Buy Recommendation for Sensorion SAS Amid Promising Audiogene Study Results and Strategic Growth Prospects
4M ago
Strategic Positioning of Sensorion SAS in the Gene Therapy Market for Hearing Loss
Premium
Ratings
Strategic Positioning of Sensorion SAS in the Gene Therapy Market for Hearing Loss
6M ago
Sensorion SAS: Promising Prospects in Hearing Loss Gene Therapy Justify Buy Rating
Premium
Ratings
Sensorion SAS: Promising Prospects in Hearing Loss Gene Therapy Justify Buy Rating
6M ago
Promising Progress in Sensorion SAS’s Gene Therapy Trials Drives Buy Rating
Premium
Ratings
Promising Progress in Sensorion SAS’s Gene Therapy Trials Drives Buy Rating
9M ago
Promising Early Data from Sensorion’s SENS-501 Study Supports Buy Rating
Premium
Ratings
Promising Early Data from Sensorion’s SENS-501 Study Supports Buy Rating
9M ago
More DE:RFM News >

RFM News on the Web

H.C. Wainwright downgrades Sensorion SAS (RFM) to a Hold
TipRanks News
Neutral
Chardan Capital Sticks to Its Buy Rating for Sensorion SAS (RFM)
TipRanks News
Bullish
Sensorion SAS (RFM) Gets a Buy from Chardan Capital
TipRanks News
Bullish
Chardan Capital Remains a Buy on Sensorion SAS (RFM)
TipRanks News
Bullish
Buy Rating on Sensorion SAS Driven by First-Mover GJB2 Gene Therapy SENS-601 and Strong Preclinical Proof-of-Concept
TipRanks News
Bullish
H.C. Wainwright Remains a Buy on Sensorion SAS (RFM)
TipRanks News
Bullish
Sensorion: Differentiated OTOF and GJB2 Gene Therapy Pipeline Positions Company for Best-in-Class Outcomes and Attractive Risk-Reward Into 2026
TipRanks News
Bullish
Sensorion SA's (EPA:ALSEN) biggest owners are private equity firms who got richer after stock soared 12% last week
Simply Wall St
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:RFM’s Media Buzz Sentiment?
Currently, no data Available
What is DE:RFM’s weekly average amount of articles?
Currently, no data Available
What is DE:RFM’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week